Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin vs Capecitabine in Advanced Breast Cancer (Study 301)
NCT00337103Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2006
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 3 trial of eribulin in breast cancer, sponsored by Eisai Co., Ltd.. Started Sep 2006; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00337103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337103.